The Effects of Bioavailability-Enhanced Curcuminoids on Serum Paraoxonase-۱ Activity in Patients with Metabolic Syndrome

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 188

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JCTM-9-4_001

تاریخ نمایه سازی: 11 دی 1400

Abstract:

Introduction: Metabolic syndrome (MetS) is characterised by a clustering of metabolic cardiovascular disease (CVD) risk factors that include: central obesity, impaired glucose metabolism, dyslipidaemia (hypertriglyceridemia, increased low-density lipoprotein [LDL], decreased high-density lipoprotein [HDL]) and hypertension. Paraoxynase-۱ (PON۱) is a plasma HDL associated protein that inhibits the oxidation of other lipoproteins. There is some evidence of reduced enzyme activity in subjects with metabolic syndrome. Curcumin is a natural polyphenol, it has been reported that curcumin has beneficial effects on several metabolic syndrome associated parameters. The aim of this study was to evaluate the effect of phospholipid complex of curcumin as an antioxidant on the activity of this enzyme in subjects with metabolic syndrome.Materials and Method: A double-blind randomised control study was undertaken in ۸۰ patients with metabolic syndrome. Subjects in the intervention (n = ۴۰) were given capsules of phospholipidated curcumin (۱ g/day) for a period of ۶ weeks. The control subjects (n = ۴۰) received a placebo. Fasting blood samples of each person were obtained during the start and the end of the study. Paraoxonase activity was measured using a PON۱ fluorescence Paraoxonase Assay Kit and Arylesterase activity was measured by photometeric method using a UV-Visible spectrophotometer.Results: Serum paraoxonase enzyme activity did not change significantly between the curcumin treated group and the control group before the intervention (۰.۵۴ ± ۰.۱۸ U/µl versus ۰.۴۹ ± ۰.۱۴ U/µl; P > ۰.۰۵), nor did serum arylesteras activity change significantly between two study groups (۱۵۲.۶۷ [۴۶.۶۰ to ۹۱۶.۰۵] U/µl versus ۱۲۹.۷۷ [۵۵.۳۴ to ۳۴۴.۷۸] U/µl; P > ۰.۰۵). In addition, there was no significant difference in changes at baseline and after the intervention in serum PON۱ activity between the curcumin treated group and the control group (-۰.۰۳±۰.۱۹ U/µl versus -۰.۰۴±۰.۱۸ U/µl; P > ۰.۰۵), nor was there a significant change in arylesteras activity (-۱۲.۳۶ [-۸۸.۸۳ to ۱۱۰.۲۴] U/µl versus -۴.۵۸ [-۶۱.۰۶ to ۴۷.۰۷] U/µl; P > ۰.۰۵).Conclusion: Phospholipid fortified curcumin has no significant effect on serum PON۱ activity. 

Authors

Atena Raee

Metabolic Syndrome Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Mohammad Reza Parizadeh

Metabolic Syndrome Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Behdokht Fathi Dizaji

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Amirhosein Sahebkar

Biotechnology Research Centre and School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Isaac Hashemy

Department of Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Maryam Saberi-Karimian

Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Majid Ghayour-Mobarhan

Cardiovascular Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Alireza Pasdar

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, ...
  • Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, ...
  • Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence ...
  • Maleki F, Sayehmiri F, Kiani F, Nasiri S. Metabolic syndrome ...
  • Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, ...
  • Mehrdad S, Hosseinpanah F, Azizi F. Metabolic syndrome prevalence in ...
  • Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome ...
  • Jalali R, Vashaghani M, Dabaghmanesh M, Ranjbar Omrani G. Metabolic ...
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. ...
  • Assmann G, Gotto AM. HDL cholesterol and protective factors in ...
  • Lee JM, Choudhury RP. Prospects for atherosclerosis regression through increase ...
  • Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, ...
  • Teiber JF, Draganov DI, La Du BN. Lactonase and lactonizing ...
  • Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, ...
  • Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of ...
  • Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, ...
  • Martinelli N, Micaglio R, Consoli L, Guarini P, Grison E, ...
  • Phuntuwate W, Suthisisang C, Koanantakul B, Mackness MI, Mackness B. ...
  • Boesch-Saadatmandi C, Egert S, Schrader C, Coumoul X, Barouki R, ...
  • Visioli F, Davalos A. Polyphenols and cardiovascular disease: a critical ...
  • Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, ...
  • Ashour M, Habib D, Hanna R, El-Dabaa M. Beneficial effects ...
  • Panahi Y, Saadat A, Beiraghdar F, Nouzari SMH, Jalalian HR, ...
  • Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, ...
  • Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, ...
  • Shin SK, Ha TY, McGregor RA, Choi MS. Long‐term curcumin ...
  • Sahebkar A. Why it is necessary to translate curcumin into ...
  • Saberi-Karimian M, Parizadeh SM, Ghayour-Mobarhan M, Salahshooh MM, Dizaji BF, ...
  • Schrader C, Schiborr C, Frank J, Rimbach G. Curcumin induces ...
  • Singh P, Ibrahim Rizvi S. Role of Curcumin in Modulating ...
  • Hasan S, Zingg J-M, Kwan P, Noble T, Smith D, ...
  • Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, ...
  • Scapagnini G, Colombrita C, Amadio M, D’Agata, V, et al. ...
  • Mattson MP. ۲۰۰۸. Hormesis defined. Ageing Research Reviews ۷: ۱-۷ ...
  • Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. ...
  • نمایش کامل مراجع